Calico

Cairn Biosciences is a San Francisco-based biotech company that specializes in discovering new medicines by mapping multiscale cell dynamics. Their proprietary COMPASS discovery platform utilizes innovative simulations of living biology to navigate complex disease biology and unlock exclusive routes to novel targets and drugs, with a focus on overcoming acquired resistance to targeted cancer therapies. With a diverse and multidisciplinary team of experts in drug discovery, disease biology, engineering, and computation, Cairn Biosciences is pioneering a new drug discovery paradigm. Their team, led by established biopharma leader and serial drug discovery innovator Mary Ludlam, is dedicated to delivering better therapeutics through their expertise in synthetic cell biology, high-throughput microscopy, computational analysis, and more.Generated from the website

Biolytic Lab Performance, Inc. is a leading provider of high-quality synthesis consumables and instruments for DNA and RNA oligo synthesis. Their Dr. Oligo synthesizers offer a range of synthesis scales and capabilities, ensuring consistent and reliable results for various applications. With a wide selection of accessories and parts, Biolytic Lab Performance also offers support and training to streamline downstream processes and optimize oligo synthesis. Headquartered in Fremont, CA, Biolytic Lab Performance is dedicated to delivering innovative solutions for the life sciences industry. Their commitment to quality and customer satisfaction has made them a trusted partner for researchers and scientists worldwide.Generated from the website

Ultragenyx Pharmaceutical Inc, based in Novato, is at the forefront of rare disease medicine, dedicated to advancing the rare disease community. With a commitment to progress and innovation, Ultragenyx is shaping the future of healthcare for those with rare diseases. Driven by a mission to propel the rare disease field forward, Ultragenyx Pharmaceutical Inc is a leader in developing treatments and therapies for those in need. Their focus on rare diseases underscores their dedication to improving the lives of patients and caregivers worldwide. Generated from their website's infomation